News

Morningstar14d
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
has approved the registration of IFINWIL® (eflornithine) for the treatment of adults and paediatric patients with high-risk neuroblastoma (HRNB), who have responded to prior multiagent ...
Nature3mon
Resurrecting the resurrection drug
Eflornithine is one such example and its development also illustrates just how far public-private partnerships have come. Eflornithine is used to treat advanced human African trypanosomiasis (HAT ...
Medindia14d
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...
KXAN14d
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
Neuroblastoma Australia welcomed the news today: "On behalf of all families of children impacted by neuroblastoma, we welcome the TGA's decision to approve IFINWIL ®. We urgently need treatments ...
Yahoo Finance14d
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
The average survival rate of children with HRNB is only 50% 2 ...
Finanznachrichten14d
Norgine welcomes TGA registration in Australia of IFINWIL (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...
Australian Associated Press14d
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
Neuroblastoma Australia welcomed the news today: "On behalf of all families of children impacted by neuroblastoma, we welcome the TGA's decision to approve IFINWIL ®. We urgently need treatments for ...